243 related articles for article (PubMed ID: 26696888)
1. The G-Protein-Coupled Bile Acid Receptor Gpbar1 (TGR5) Inhibits Gastric Inflammation Through Antagonizing NF-κB Signaling Pathway.
Guo C; Qi H; Yu Y; Zhang Q; Su J; Yu D; Huang W; Chen WD; Wang YD
Front Pharmacol; 2015; 6():287. PubMed ID: 26696888
[TBL] [Abstract][Full Text] [Related]
2. The G-protein-coupled bile acid receptor Gpbar1 (TGR5) protects against renal inflammation and renal cancer cell proliferation and migration through antagonizing NF-κB and STAT3 signaling pathways.
Su J; Zhang Q; Qi H; Wu L; Li Y; Yu D; Huang W; Chen WD; Wang YD
Oncotarget; 2017 Aug; 8(33):54378-54387. PubMed ID: 28903349
[TBL] [Abstract][Full Text] [Related]
3. The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor κ light-chain enhancer of activated B cells (NF-κB) in mice.
Wang YD; Chen WD; Yu D; Forman BM; Huang W
Hepatology; 2011 Oct; 54(4):1421-32. PubMed ID: 21735468
[TBL] [Abstract][Full Text] [Related]
4. The G-protein-coupled bile acid receptor Gpbar1 (TGR5) suppresses gastric cancer cell proliferation and migration through antagonizing STAT3 signaling pathway.
Guo C; Su J; Li Z; Xiao R; Wen J; Li Y; Zhang M; Zhang X; Yu D; Huang W; Chen WD; Wang YD
Oncotarget; 2015 Oct; 6(33):34402-13. PubMed ID: 26417930
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of G-protein-coupled bile acid receptor Gpbar1 (TGR5) enhances chemically induced liver carcinogenesis.
Chen WD; Yu D; Forman BM; Huang W; Wang YD
Hepatology; 2013 Feb; 57(2):656-66. PubMed ID: 22911633
[TBL] [Abstract][Full Text] [Related]
6. Gentiopicroside activates the bile acid receptor Gpbar1 (TGR5) to repress NF-kappaB pathway and ameliorate diabetic nephropathy.
Xiao H; Sun X; Liu R; Chen Z; Lin Z; Yang Y; Zhang M; Liu P; Quan S; Huang H
Pharmacol Res; 2020 Jan; 151():104559. PubMed ID: 31759089
[TBL] [Abstract][Full Text] [Related]
7. Activation of G-protein-coupled bile acid receptor Gpbar1 (TGR5) inhibits degradation of type II collagen and aggrecan in human chondrocytes.
Zhuo W; Li B; Zhang D
Eur J Pharmacol; 2019 Aug; 856():172387. PubMed ID: 31075239
[TBL] [Abstract][Full Text] [Related]
8. TGR5 agonist INT-777 mitigates inflammatory response in human endometriotic stromal cells: A therapeutic implication for endometriosis.
Lyu D; Tang N; Wang J; Zhang Y; Chang J; Liu Z; Liu H
Int Immunopharmacol; 2019 Jun; 71():93-99. PubMed ID: 30878820
[TBL] [Abstract][Full Text] [Related]
9. Plasma membrane-bound G protein-coupled bile acid receptor attenuates liver ischemia/reperfusion injury via the inhibition of toll-like receptor 4 signaling in mice.
Yang H; Zhou H; Zhuang L; Auwerx J; Schoonjans K; Wang X; Feng C; Lu L
Liver Transpl; 2017 Jan; 23(1):63-74. PubMed ID: 27597295
[TBL] [Abstract][Full Text] [Related]
10. TGR5, Not Only a Metabolic Regulator.
Guo C; Chen WD; Wang YD
Front Physiol; 2016; 7():646. PubMed ID: 28082913
[TBL] [Abstract][Full Text] [Related]
11. TGR5 suppresses high glucose-induced upregulation of fibronectin and transforming growth factor-β1 in rat glomerular mesangial cells by inhibiting RhoA/ROCK signaling.
Xiong F; Li X; Yang Z; Wang Y; Gong W; Huang J; Chen C; Liu P; Huang H
Endocrine; 2016 Dec; 54(3):657-670. PubMed ID: 27470217
[TBL] [Abstract][Full Text] [Related]
12. Effects of Farnesiferol B on Ischemia-Reperfusion-Induced Renal Damage, Inflammation, and NF-κB Signaling.
Zhang L; Fu X; Gui T; Wang T; Wang Z; Kullak-Ublick GA; Gai Z
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842453
[TBL] [Abstract][Full Text] [Related]
13. Activation of the bile acid receptor TGR5 enhances LPS-induced inflammatory responses in a human monocytic cell line.
Mobraten K; Haugbro T; Karlstrom E; Kleiveland CR; Lea T
J Recept Signal Transduct Res; 2015; 35(5):402-9. PubMed ID: 25418122
[TBL] [Abstract][Full Text] [Related]
14. The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines.
Carino A; Graziosi L; D'Amore C; Cipriani S; Marchianò S; Marino E; Zampella A; Rende M; Mosci P; Distrutti E; Donini A; Fiorucci S
Oncotarget; 2016 Sep; 7(38):61021-61035. PubMed ID: 27409173
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of TGR5 exacerbates immune-mediated cholestatic hepatic injury by stabilizing the β-catenin destruction complex.
Rao J; Yang C; Yang S; Lu H; Hu Y; Lu L; Cheng F; Wang X
Int Immunol; 2020 May; 32(5):321-334. PubMed ID: 31930324
[TBL] [Abstract][Full Text] [Related]
16. TGR5 in inflammation and cardiovascular disease.
Pols TW
Biochem Soc Trans; 2014 Apr; 42(2):244-9. PubMed ID: 24646225
[TBL] [Abstract][Full Text] [Related]
17. TGR5 protects against cholestatic liver disease via suppressing the NF-κB pathway and activating the Nrf2/HO-1 pathway.
Yang H; Luo F; Wei Y; Jiao Y; Qian J; Chen S; Gong Y; Tang L
Ann Transl Med; 2021 Jul; 9(14):1158. PubMed ID: 34430599
[TBL] [Abstract][Full Text] [Related]
18. G-protein-coupled bile acid receptor 1 (GPBAR1, TGR5) agonists reduce the production of proinflammatory cytokines and stabilize the alternative macrophage phenotype.
Högenauer K; Arista L; Schmiedeberg N; Werner G; Jaksche H; Bouhelal R; Nguyen DG; Bhat BG; Raad L; Rauld C; Carballido JM
J Med Chem; 2014 Dec; 57(24):10343-54. PubMed ID: 25411721
[TBL] [Abstract][Full Text] [Related]
19. The G Protein-Coupled Bile Acid Receptor TGR5 (Gpbar1) Modulates Endothelin-1 Signaling in Liver.
Klindt C; Reich M; Hellwig B; Stindt J; Rahnenführer J; Hengstler JG; Köhrer K; Schoonjans K; Häussinger D; Keitel V
Cells; 2019 Nov; 8(11):. PubMed ID: 31752395
[TBL] [Abstract][Full Text] [Related]
20. Deoxycholic acid inhibits Staphylococcus aureus-induced endometritis through regulating TGR5/PKA/NF-κB signaling pathway.
Zhao W; Wang J; Li X; Li Y; Ye C
Int Immunopharmacol; 2023 May; 118():110004. PubMed ID: 36958214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
